Management of atrial fibrillation still suboptimal in Europe

ESC presents preliminary results of Atrial Fibrillation General Registry: Statistics show that oral anticoagulant use has increased, but new oral anticoagulant (NOAC) use is still low. Authors also concluded that compliance with treatment guidelines for patients with the lowest and higher stroke risk scores remains suboptimal. Topics: Atrial Fibrillation
Source: ESC News and Press - Category: Cardiology Source Type: news